Doryx work for
AGIPNEWS6638 Warner Chilcott Files Lawsuits for Infringement of DORYX Patent ag-ip-news.com (Intellectual Property News Agency) ST. DAVID'S, BERMUDA - Warner Chilcott Limited (WCRX) announced in a press release that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne"), a subsidiary of Hospira, Inc., have filed lawsuits against each of Mutual Pharmaceutical Company Inc. (Mutual), Mylan Pharmaceuticals Inc. (Mylan) and Impax Laboratories Inc. (Impax).75 mg DORYX Pill Identification Warner Chilcott Files New Lawsuit for Infringement of DORYX(r) Patent - News Story - Biocompare Buyer's Guide For Life Scientists Warner Chilcott Limited announced today that one of its subsidiaries and Mayne Pharma International Pty. Ltd. ("Mayne") have filed a second lawsuit against Impax Laboratories, Inc. ("Impax") in the District Court for the District of New Jersey for infringement of Mayne's U.S. Patent No. 6,958,161 (the "'161 Patent") which covers DORYX, a tetracycline-class oral antibiotic. The lawsuit is in response to the submission of an Abbreviated New Drug Application ("ANDA") to the U.S. Food and Drug Administration ("FDA") by Impax requesting approval to manufacture and sell a generic version of DORYX 150 mg delayed-release tablets prior to the expiration in 2022 of the '161 Patent.